1. Drugs in Development for Tuberculosis

   • Ann M. Ginsberg

   Leading Article 29 November 2012 Pages: 2201 - 2214

   

2. Pharmacological Management of Essential Tremor

   • Reza Sadeghi
   • William G. Ondo

   Review Article 29 November 2012 Pages: 2215 - 2228

   

3. Influence of Intensive versus Conventional Glucose Control on Microvascular and Macrovascular Complications in Type 1 and 2 Diabetes Mellitus

   • Taina K. Mattila
   • Anthonius de Boer

   Review Article 29 November 2012 Pages: 2229 - 2245

   

4. Triple-Negative Breast Cancer

   • Shaheenah Dawood

   Review Article 29 November 2012 Pages: 2247 - 2258

   

5. Trastuzumab

   • Jamie D. Croxtall
   • Kate McKeage

   Adis Drug Profile 29 November 2012 Pages: 2259 - 2267

   

6. Indacaterol

   • Marit D. Moen

   Adis Drug Profile 29 November 2012 Pages: 2269 - 2280

   

7. Fentanyl Sublingual

   • Claudine M. Chwieduk
   • Kate McKeage

   Adis Drug Profile 29 November 2012 Pages: 2281 - 2288

   

8. Olanzapine Long-Acting Injection

   • James E. Frampton

   Adis Drug Evaluation 29 November 2012 Pages: 2289 - 2313

   

9. Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (Atripla®)

   • Emma D. Deeks
   • Caroline M. Perry

   Adis Drug Evaluation 29 November 2012 Pages: 2315 - 2338